Literature DB >> 1656470

The role of endogenous opioids and their receptors in the immune system.

D J Carr1.   

Abstract

Opioid peptides appear to be dynamic signaling molecules that are produced within the immune system and are active regulators of an immune response. Furthermore, the receptors for these peptides occurring on immunocyte membranes share characteristics with neuronal opioid receptors, including molecular size, immunogenicity, and the use of specific intracellular signaling pathways. Recent studies of the interaction of opioids with cytokines have indicated that opioid peptides are intimately involved within the immune system. Specifically, opioids, including 2-n-pentyloxy-2-phenyl-4-methyl-morpholine, naloxone, and beta-endorphin, have been shown to interact with IL-2 receptors (134) and regulate production of IL-1 and IL-2 (48-50, 135). Conversely, IL-1 has been shown to up-regulate opioid peptide binding in brain tissue (136). Furthermore, the induction of IL-1 by opioids has also been identified in the invertebrate Mytilus, indicating the evolutionary conservation of this relationship (137). These results seem to typify the intricate association between the immune and neuroendocrine systems through opioid pathways. It is predicted that future endeavors will use this relationship to diagnose and treat specific diseases that have at their basis neuroendocrine and immunologic imbalances.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656470     DOI: 10.3181/00379727-198-43309b

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  10 in total

1.  β-endorphin binding in cultured adrenal cortical cells.

Authors:  R A Gelfand; A Bobrow; L Pham; C Young; L Parker
Journal:  Endocrine       Date:  1995-03       Impact factor: 3.633

2.  Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats.

Authors:  P J Cabot; L Carter; C Gaiddon; Q Zhang; M Schäfer; J P Loeffler; C Stein
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 3.  Intensive Care Unit-acquired infection as a side effect of sedation.

Authors:  Saad Nseir; Demosthenes Makris; Daniel Mathieu; Alain Durocher; Charles-Hugo Marquette
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

4.  LVV-hemorphin-4 modulates Ca2+/calmodulin-dependent pathways in the immune system by the same mechanism as in the brain.

Authors:  Nina Barkhudaryan; Spartak Gambarov; Tadevos Gyulbayazyan; Karine Nahapetyan
Journal:  J Mol Neurosci       Date:  2002-06       Impact factor: 3.444

Review 5.  Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.

Authors:  Matias Jaureguiberry-Bravo; Rebecca Wilson; Loreto Carvallo; Joan W Berman
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

6.  Behavioural, Mucosal and Systemic Immune Parameters in HIV-infected and Uninfected Injection Drug Users.

Authors:  Saurabh Mehandru; Sherry Deren; Sung-Yeon Kang; Angela Banfield; Aakash Garg; Donald Garmon; Melissa LaMar; Teresa H Evering; Martin Markowitz
Journal:  J Addict Res Ther       Date:  2015

7.  Enhancement of Meditation Analgesia by Opioid Antagonist in Experienced Meditators.

Authors:  Lisa M May; Peter Kosek; Fadel Zeidan; Elliot T Berkman
Journal:  Psychosom Med       Date:  2018 Nov/Dec       Impact factor: 4.312

8.  Acute and short-term administrations of delta-9-tetrahydrocannabinol modulate major gut metabolomic regulatory pathways in C57BL/6 mice.

Authors:  Megha Oza; William Becker; Phani M Gummadidala; Travis Dias; Mayomi H Omebeyinje; Li Chen; Chandrani Mitra; Rubaiya Jesmin; Paramita Chakraborty; Mathew Sajish; Lorne J Hofseth; Koyeli Banerjee; Qian Wang; Peter D R Moeller; Mitzi Nagarkatti; Prakash Nagarkatti; Anindya Chanda
Journal:  Sci Rep       Date:  2019-07-19       Impact factor: 4.379

9.  Effects of opiate dependence through different administration routes on pulmonary inflammation and its severity.

Authors:  Mohammad Masoomi; Marzieh Tajoddini; Gholamabbas Mohammadi; Reza Malekpoor; Ebrahim Abasi
Journal:  Iran Red Crescent Med J       Date:  2013-10-05       Impact factor: 0.611

10.  Beta-endorphin protects mice from neurological disease induced by the murine coronavirus MHV-JHM.

Authors:  W Gilmore; D S Moradzadeh
Journal:  J Neuroimmunol       Date:  1993-10       Impact factor: 3.478

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.